HK1088225A1 - Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n - Google Patents

Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n

Info

Publication number
HK1088225A1
HK1088225A1 HK06108551A HK06108551A HK1088225A1 HK 1088225 A1 HK1088225 A1 HK 1088225A1 HK 06108551 A HK06108551 A HK 06108551A HK 06108551 A HK06108551 A HK 06108551A HK 1088225 A1 HK1088225 A1 HK 1088225A1
Authority
HK
Hong Kong
Prior art keywords
compoundsfor
pai
immunomodulatory
compositions
management
Prior art date
Application number
HK06108551A
Inventor
Jerome B Zeldis
Herbert Faleck
Donald C Manning
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of HK1088225A1 publication Critical patent/HK1088225A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK06108551A 2002-10-24 2006-08-01 Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n HK1088225A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42100302P 2002-10-24 2002-10-24
PCT/US2003/033757 WO2004037199A2 (en) 2002-10-24 2003-10-24 Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain

Publications (1)

Publication Number Publication Date
HK1088225A1 true HK1088225A1 (en) 2006-11-03

Family

ID=32176661

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06108551A HK1088225A1 (en) 2002-10-24 2006-08-01 Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n

Country Status (13)

Country Link
EP (1) EP1556044A2 (en)
JP (1) JP2006507284A (en)
KR (1) KR20050057672A (en)
CN (2) CN101108185A (en)
AU (1) AU2003286663B2 (en)
BR (1) BR0315609A (en)
CA (1) CA2503536A1 (en)
HK (1) HK1088225A1 (en)
MX (1) MXPA05004182A (en)
NZ (1) NZ540028A (en)
TW (1) TW200503683A (en)
WO (1) WO2004037199A2 (en)
ZA (1) ZA200503240B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228769B1 (en) 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
US20050203142A1 (en) * 2002-10-24 2005-09-15 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
US7563810B2 (en) * 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US20050143344A1 (en) * 2003-12-30 2005-06-30 Zeldis Jerome B. Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
US20050222209A1 (en) * 2004-04-01 2005-10-06 Zeldis Jerome B Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
US20080300262A1 (en) * 2005-04-08 2008-12-04 Snutch Terrance P Combination Therapy for Relief of Pain
US20070066512A1 (en) * 2005-09-12 2007-03-22 Dominique Verhelle Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
JP4382735B2 (en) * 2005-10-06 2009-12-16 独立行政法人科学技術振興機構 Neuropathic pain treatment
JP2009538318A (en) * 2006-05-26 2009-11-05 セルジーン・コーポレーション Methods and compositions using immunomodulatory compounds in combination therapy
WO2008057196A2 (en) * 2006-10-19 2008-05-15 Celgene Corporation Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
CN101696205B (en) 2009-11-02 2011-10-19 南京卡文迪许生物工程技术有限公司 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215114A (en) * 1976-11-12 1980-07-29 The Upjohn Company Analgesic N-[2-(furyl-methylamino and 2-thienylmethylamino)cycloaliphatic]be
US6281230B1 (en) * 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
PT2177517E (en) * 1996-07-24 2011-11-10 Celgene Corp Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing tnf alpha levels
US5955476A (en) * 1997-11-18 1999-09-21 Celgene Corporation Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
US20030045552A1 (en) * 2000-12-27 2003-03-06 Robarge Michael J. Isoindole-imide compounds, compositions, and uses thereof
SE0101256D0 (en) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of low back pain

Also Published As

Publication number Publication date
AU2003286663A1 (en) 2004-05-13
MXPA05004182A (en) 2005-06-08
CN1732000A (en) 2006-02-08
AU2003286663B2 (en) 2009-08-13
CA2503536A1 (en) 2004-05-06
KR20050057672A (en) 2005-06-16
JP2006507284A (en) 2006-03-02
NZ540028A (en) 2009-07-31
CN101108185A (en) 2008-01-23
WO2004037199A2 (en) 2004-05-06
CN1326522C (en) 2007-07-18
TW200503683A (en) 2005-02-01
BR0315609A (en) 2005-08-23
WO2004037199A3 (en) 2004-12-23
ZA200503240B (en) 2007-11-28
EP1556044A2 (en) 2005-07-27

Similar Documents

Publication Publication Date Title
HK1088225A1 (en) Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n
EP1551376A4 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
EP1680111A4 (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
AU2003257937A8 (en) Methods and compositions for treatment of dermal conditions
IL166608A0 (en) Anti-microbial compositions and methods of using same
AU2003259735A8 (en) Small-mer compositions and methods of use
HK1081957A1 (en) Benzopyranone compounds, compositions thereof, and methods of treatment therewith
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1651255A4 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
GB0303609D0 (en) Novel therapeutic method and compositions
AU2003213120A8 (en) Human rnase iii and compositions and uses thereof
AU2003233445A1 (en) Antimicrobial compositions and methods of use
AU2003296963A8 (en) Methods and compositions for treating and preventing ear infections
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
EP1575503A4 (en) Compositions and methods for treating and preventing infection
GB0324523D0 (en) Compositions and methods of treatment
GB0205531D0 (en) Hair treatment compositions
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003275069A8 (en) Compositions and methods for preventing infection
AU2003303948A8 (en) Compositions and methods for preventing infection
AU2003282593A8 (en) Polyphenolamine composition and method of use
GB0300078D0 (en) Composition for the treatment of HIV and AIDS
AU2003275433A8 (en) Compositions and methods for treating pain
AU2003207315A1 (en) Treatment of muscle damage

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111024